Related Experiment Video
Updated: Jul 24, 2026
15:15
Flow Cytometry Analysis of Immune Cells Within Murine Aortas
Published on: July 1, 2011
Gamma interferon: a central mediator in atherosclerosis.
M L Alfaro Leon1, S H Zuckerman
1Universidad Autonoma Metropolitana-Xochimilco, Ciencias Biologicas , Xochimilco, Mexico.
Summary
Gamma interferon (IFN-γ) drives atherosclerosis plaque pathology. Therapies targeting IFN-γ signaling may offer new treatments beyond lipid lowering for this inflammatory vascular disease.
Area of Science:
- Vascular biology
- Immunology
- Inflammation
Background:
- Atherosclerosis is a chronic inflammatory vascular disease.
- Immune cells like macrophages and lymphocytes interact within arterial lesions.
- Gamma interferon (IFN-γ), a key macrophage activator, is found in atherosclerotic plaques.
Purpose of the Study:
- To review the role of IFN-γ in atherosclerotic plaque pathology.
- To explore how therapies like statins may inhibit IFN-γ dependent processes.
- To consider novel therapeutic strategies targeting IFN-γ signaling.
Main Methods:
- Review of existing literature on IFN-γ in atherosclerosis.
- Analysis of IFN-γ sources, receptors, and signaling pathways.
- Examination of IFN-γ effects on vascular cells and macrophages.
Main Results:
- IFN-γ contributes to the progression of atherosclerotic lesions.
- Statins may exert anti-atherosclerotic effects by inhibiting IFN-γ.
- Understanding IFN-γ pathways reveals potential therapeutic targets.
Conclusions:
- IFN-γ is a significant factor in atherosclerosis pathogenesis.
- Targeting IFN-γ signaling presents a promising therapeutic avenue.
- Novel treatments could modulate immune responses in vascular disease.
Related Concept Videos
01:38Inflammation
Overview
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...